Used in pharmaceutical research as a key intermediate in the synthesis of targeted protein degraders, particularly cereblon E3 ligase modulators. Its structure enables selective binding to cereblon, making it valuable in developing therapeutics for cancer and inflammatory diseases. It is also explored in the design of PROTACs (proteolysis-targeting chimeras) for degrading disease-causing proteins.